90 related articles for article (PubMed ID: 38741146)
21. Membrane-Initiated Estrogen, Androgen, and Progesterone Receptor Signaling in Health and Disease.
Mauvais-Jarvis F; Lange CA; Levin ER
Endocr Rev; 2022 Jul; 43(4):720-742. PubMed ID: 34791092
[TBL] [Abstract][Full Text] [Related]
22. Estetrol and Mammary Gland: Friends or Foes?
Gallez A; Dias Da Silva I; Wuidar V; Foidart JM; Péqueux C
J Mammary Gland Biol Neoplasia; 2021 Sep; 26(3):297-308. PubMed ID: 34463898
[TBL] [Abstract][Full Text] [Related]
23. Estetrol Combined to Progestogen for Menopause or Contraception Indication Is Neutral on Breast Cancer.
Gallez A; Blacher S; Maquoi E; Konradowski E; Joiret M; Primac I; Gérard C; Taziaux M; Houtman R; Geris L; Lenfant F; Marangoni E; Sounni NE; Foidart JM; Noël A; Péqueux C
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34065180
[TBL] [Abstract][Full Text] [Related]
24. Estetrol-drospirenone combination oral contraceptive: North American phase 3 efficacy and safety results.
Creinin MD; Westhoff CL; Bouchard C; Chen MJ; Jensen JT; Kaunitz AM; Achilles SL; Foidart JM; Archer DF
Contraception; 2021 Sep; 104(3):222-228. PubMed ID: 34000251
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic Perspectives on the Modulation of G-Protein Coupled Estrogen Receptor, GPER, Function.
Rouhimoghadam M; Lu AS; Salem AK; Filardo EJ
Front Endocrinol (Lausanne); 2020; 11():591217. PubMed ID: 33329395
[TBL] [Abstract][Full Text] [Related]
26. Tumor suppression, dose-limiting toxicity and wellbeing with the fetal estrogen estetrol in patients with advanced breast cancer.
Schmidt M; Lenhard H; Hoenig A; Zimmerman Y; Krijgh J; Jansen M; Coelingh Bennink HJT
J Cancer Res Clin Oncol; 2021 Jun; 147(6):1833-1842. PubMed ID: 33242131
[TBL] [Abstract][Full Text] [Related]
27. Computational Approaches for the Discovery of GPER Targeting Compounds.
Grande F; Occhiuzzi MA; Lappano R; Cirillo F; Guzzi R; Garofalo A; Jacquot Y; Maggiolini M; Rizzuti B
Front Endocrinol (Lausanne); 2020; 11():517. PubMed ID: 32849301
[TBL] [Abstract][Full Text] [Related]
28. Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer.
Abderrahman B; Maximov PY; Curpan RF; Hanspal JS; Fan P; Xiong R; Tonetti DA; Thatcher GRJ; Jordan VC
Mol Pharmacol; 2020 Oct; 98(4):364-381. PubMed ID: 32788222
[TBL] [Abstract][Full Text] [Related]
29. The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).
Lappano R; Talia M; Cirillo F; Rigiracciolo DC; Scordamaglia D; Guzzi R; Miglietta AM; De Francesco EM; Belfiore A; Sims AH; Maggiolini M
J Exp Clin Cancer Res; 2020 Aug; 39(1):153. PubMed ID: 32778144
[TBL] [Abstract][Full Text] [Related]
30. The G Protein-Coupled Estrogen Receptor (GPER) Expression Correlates with Pro-Metastatic Pathways in ER-Negative Breast Cancer: A Bioinformatics Analysis.
Talia M; De Francesco EM; Rigiracciolo DC; Muoio MG; Muglia L; Belfiore A; Maggiolini M; Sims AH; Lappano R
Cells; 2020 Mar; 9(3):. PubMed ID: 32143514
[TBL] [Abstract][Full Text] [Related]
31. AHR and GPER mediate the stimulatory effects induced by 3-methylcholanthrene in breast cancer cells and cancer-associated fibroblasts (CAFs).
Cirillo F; Lappano R; Bruno L; Rizzuti B; Grande F; Guzzi R; Briguori S; Miglietta AM; Nakajima M; Di Martino MT; Maggiolini M
J Exp Clin Cancer Res; 2019 Aug; 38(1):335. PubMed ID: 31370872
[TBL] [Abstract][Full Text] [Related]
32. The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer Cells.
Lappano R; Mallet C; Rizzuti B; Grande F; Galli GR; Byrne C; Broutin I; Boudieu L; Eschalier A; Jacquot Y; Maggiolini M
Cells; 2019 Jun; 8(6):. PubMed ID: 31207943
[TBL] [Abstract][Full Text] [Related]
33. Estrogen receptor signaling mechanisms.
Fuentes N; Silveyra P
Adv Protein Chem Struct Biol; 2019; 116():135-170. PubMed ID: 31036290
[TBL] [Abstract][Full Text] [Related]
34. Androgens Induce Invasiveness of Triple Negative Breast Cancer Cells Through AR/Src/PI3-K Complex Assembly.
Giovannelli P; Di Donato M; Auricchio F; Castoria G; Migliaccio A
Sci Rep; 2019 Mar; 9(1):4490. PubMed ID: 30872694
[TBL] [Abstract][Full Text] [Related]
35. fastp: an ultra-fast all-in-one FASTQ preprocessor.
Chen S; Zhou Y; Chen Y; Gu J
Bioinformatics; 2018 Sep; 34(17):i884-i890. PubMed ID: 30423086
[TBL] [Abstract][Full Text] [Related]
36. The release of cardioprotective humoral factors after remote ischemic preconditioning in humans is age- and sex-dependent.
Heinen A; Behmenburg F; Aytulun A; Dierkes M; Zerbin L; Kaisers W; Schaefer M; Meyer-Treschan T; Feit S; Bauer I; Hollmann MW; Huhn R
J Transl Med; 2018 Apr; 16(1):112. PubMed ID: 29703217
[TBL] [Abstract][Full Text] [Related]
37. Contemporary Hormonal Contraception and the Risk of Breast Cancer.
Mørch LS; Skovlund CW; Hannaford PC; Iversen L; Fielding S; Lidegaard Ø
N Engl J Med; 2017 Dec; 377(23):2228-2239. PubMed ID: 29211679
[TBL] [Abstract][Full Text] [Related]
38. Estrogen Hormone Biology.
Hamilton KJ; Hewitt SC; Arao Y; Korach KS
Curr Top Dev Biol; 2017; 125():109-146. PubMed ID: 28527569
[TBL] [Abstract][Full Text] [Related]
39. Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers.
Chiu JH; Wen CS; Wang JY; Hsu CY; Tsai YF; Hung SC; Tseng LM; Shyr YM
J Transl Med; 2017 May; 15(1):97. PubMed ID: 28472954
[TBL] [Abstract][Full Text] [Related]
40. Twenty years of the G protein-coupled estrogen receptor GPER: Historical and personal perspectives.
Barton M; Filardo EJ; Lolait SJ; Thomas P; Maggiolini M; Prossnitz ER
J Steroid Biochem Mol Biol; 2018 Feb; 176():4-15. PubMed ID: 28347854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
